Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer

Author：

E-ISSN： 1792-1082|10|2|647-652

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.2, 2015-01, pp. : 647-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1113-1116

Science Publishers

Access to resources Recommend Favorite

Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1103-1108

Science Publishers

Access to resources Recommend Favorite

Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer

Oncology Letters, Vol. 4, Iss. 2, 2012-01 ,pp. : 334-338

Spandidos Publications

Access to resources Recommend Favorite